• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性耳念珠菌感染治疗的药效学优化

Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.

作者信息

Lepak Alexander J, Zhao Miao, Berkow Elizabeth L, Lockhart Shawn R, Andes David R

机构信息

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, USA.

出版信息

Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00791-17. Print 2017 Aug.

DOI:10.1128/AAC.00791-17
PMID:28584152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5527602/
Abstract

is an emerging multidrug-resistant threat. The pharmacodynamics of three antifungal classes against nine strains was explored using a murine invasive candidiasis model. The total drug median pharmacodynamic (PD) target associated with net stasis was a fluconazole AUC/MIC (the area under the concentration-time curve over 24 h in the steady state divided by the MIC) of 26, an amphotericin B /MIC (maximum concentration of drug in serum divided by the MIC) of 0.9, and a micafungin AUC/MIC of 54. The micafungin PD targets for were ≥20-fold lower than those of other species in this animal model. Clinically relevant micafungin exposures produced the most killing among the three classes.

摘要

是一种新出现的多重耐药威胁。使用小鼠侵袭性念珠菌病模型探索了三类抗真菌药物对九种菌株的药效学。与净停滞相关的总药物中位药效学(PD)靶点为:氟康唑的AUC/MIC(稳态下24小时浓度-时间曲线下面积除以MIC)为26,两性霉素B的Cmax/MIC(血清中药物最大浓度除以MIC)为0.9,米卡芬净的AUC/MIC为54。在该动物模型中,米卡芬净对[具体物种未给出]的PD靶点比其他[具体物种未给出]物种低≥20倍。临床相关的米卡芬净暴露在这三类药物中产生的杀菌效果最佳。

相似文献

1
Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.侵袭性耳念珠菌感染治疗的药效学优化
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00791-17. Print 2017 Aug.
2
Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak.针对来自纽约疫情的多重耐药耳念珠菌分离株的抗真菌药物联合评估
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02195-19.
3
Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.重症侵袭性念珠菌病患者米卡芬净的药代动力学特征。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01398-17. Print 2017 Dec.
4
Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.米卡芬净治疗连续性静脉-静脉血液滤过治疗危重症侵袭性念珠菌病患者的药代动力学/药效学适宜性。
J Antimicrob Chemother. 2014 Jun;69(6):1624-32. doi: 10.1093/jac/dku013. Epub 2014 Feb 5.
5
Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.米卡芬净:关于其在成人中用于治疗侵袭性念珠菌病和食管念珠菌病以及预防念珠菌感染的综述。
Drugs. 2008;68(15):2225-55. doi: 10.2165/00003495-200868150-00010.
6
Recent increase in frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization.SENTRY 监测项目中频率的近期增加:抗真菌活性和基因型特征。
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0057024. doi: 10.1128/aac.00570-24. Epub 2024 Sep 12.
7
Candida auris and multidrug resistance: Defining the new normal.耳念珠菌和多重耐药性:定义新常态。
Fungal Genet Biol. 2019 Oct;131:103243. doi: 10.1016/j.fgb.2019.103243. Epub 2019 Jun 20.
8
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.了解新兴病原体耳念珠菌的棘白菌素类耐药性。
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00238-18. Print 2018 Jun.
9
Assessment of echinocandin regimens by pharmacokinetic/pharmacodynamic analysis against Candida spp. in paediatric patients.评估基于药代动力学/药效学分析的棘白菌素方案对儿科患者念珠菌属的疗效。
Int J Antimicrob Agents. 2015 Dec;46(6):631-41. doi: 10.1016/j.ijantimicag.2015.08.009. Epub 2015 Sep 21.
10
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.三级医疗机构外科重症监护病房(SICU)的念珠菌监测
BMC Infect Dis. 2015 Jul 3;15:256. doi: 10.1186/s12879-015-0997-6.

引用本文的文献

1
infection at a pediatric burn center: Treatment and infection control measures.儿科烧伤中心的感染:治疗与感染控制措施
North Clin Istanb. 2025 Jun 11;12(3):285-289. doi: 10.14744/nci.2024.26429. eCollection 2025.
2
: Epidemiology and Antifungal Strategy.流行病学与抗真菌策略
Annu Rev Med. 2025 Jan;76(1):57-67. doi: 10.1146/annurev-med-061523-021233. Epub 2025 Jan 16.
3
Analogs of the anti-malaria drug mefloquine have broad-spectrum antifungal activity and are efficacious in a model of disseminated infection.抗疟疾药物甲氟喹类似物具有广谱抗真菌活性,并在播散性感染模型中有效。
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0130124. doi: 10.1128/aac.01301-24. Epub 2024 Oct 4.
4
In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Clades in a Neutropenic Mouse Bloodstream Infection Model.瑞扎芬净、阿尼芬净、卡泊芬净和米卡芬净在中性粒细胞减少小鼠血流感染模型中对四个进化枝的体内疗效。
J Fungi (Basel). 2024 Aug 29;10(9):617. doi: 10.3390/jof10090617.
5
Analogues of the anti-malaria drug mefloquine have broad spectrum antifungal activity and are efficacious in a model of disseminated infection.抗疟疾药物甲氟喹的类似物具有广谱抗真菌活性,并且在播散性感染模型中有效。
bioRxiv. 2024 Aug 30:2024.08.29.610379. doi: 10.1101/2024.08.29.610379.
6
Act Now: The Global Threat of Candida Auris and the Urgent Need for Effective Countermeasures.立即行动:耳念珠菌的全球威胁与有效应对措施的迫切需求。
J Community Hosp Intern Med Perspect. 2024 Mar 4;14(2):120-123. doi: 10.55729/2000-9666.1303. eCollection 2024.
7
Meeting the Therapeutic Challenges of Emergent and Rare Invasive Fungal Diseases Through Novel Clinical Trial Designs.通过新型临床试验设计应对紧急和罕见侵袭性真菌病的治疗挑战。
Open Forum Infect Dis. 2024 Jun 17;11(6):ofae257. doi: 10.1093/ofid/ofae257. eCollection 2024 Jun.
8
The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England.实验室调查、管理以及感染预防和控制:一篇叙述性综述,旨在为 2024 年英格兰国家指南更新提供信息。
J Med Microbiol. 2024 May;73(5). doi: 10.1099/jmm.0.001820.
9
Outbreak in a Multidisciplinary Hospital in Romania during the Post-Pandemic Era: Potential Solutions and Challenges in Surveillance and Epidemiological Control.后疫情时代罗马尼亚一家多学科医院的疫情爆发:监测与流行病学控制中的潜在解决方案与挑战
Antibiotics (Basel). 2024 Apr 3;13(4):325. doi: 10.3390/antibiotics13040325.
10
Emergence of highly resistant in the United Arab Emirates: a retrospective analysis of evolving national trends.在阿拉伯联合酋长国出现高度耐药的:对不断变化的国家趋势的回顾性分析。
Front Public Health. 2024 Jan 12;11:1244358. doi: 10.3389/fpubh.2023.1244358. eCollection 2023.

本文引用的文献

1
Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins.在英国发现的新兴病原体耳念珠菌的分离株有多个地理来源。
Med Mycol. 2017 Jul 1;55(5):563-567. doi: 10.1093/mmy/myw147.
2
Nosocomial fungemia by Candida auris: First four reported cases in continental Europe.耳念珠菌引起的医院获得性真菌血症:欧洲大陆报告的首例4例病例
Rev Iberoam Micol. 2017 Jan-Mar;34(1):23-27. doi: 10.1016/j.riam.2016.11.002. Epub 2017 Jan 25.
3
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.高毒力、多重耐药耳念珠菌的生物膜形成能力
Emerg Infect Dis. 2017 Feb;23(2):328-331. doi: 10.3201/eid2302.161320.
4
Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.多重耐药的哈氏假丝酵母菌和耳念珠菌,以色列特拉维夫
Emerg Infect Dis. 2017 Feb;23(1):195-203. doi: 10.3201/eid2302.161486.
5
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.全基因组测序和流行病学分析证实三大洲同时出现多重耐药性耳念珠菌
Clin Infect Dis. 2017 Jan 15;64(2):134-140. doi: 10.1093/cid/ciw691. Epub 2016 Oct 20.
6
Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia.哥伦比亚多重耐药酵母耳念珠菌的侵袭性感染
Emerg Infect Dis. 2017 Jan;23(1):162-164. doi: 10.3201/eid2301.161497.
7
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016.调查美国 2013 年 5 月至 2016 年 8 月首例报告的 7 例耳念珠菌感染病例,这是一种全球新兴的侵袭性、多药耐药真菌。
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1234-1237. doi: 10.15585/mmwr.mm6544e1.
8
Hospital transmitted Candida auris infections confirmed in the US.美国确诊医院传播的耳念珠菌感染。
BMJ. 2016 Nov 7;355:i5978. doi: 10.1136/bmj.i5978.
9
First hospital outbreak of the globally emerging in a European hospital.全球新出现的首例医院感染事件发生在一家欧洲医院。
Antimicrob Resist Infect Control. 2016 Oct 19;5:35. doi: 10.1186/s13756-016-0132-5. eCollection 2016.
10
Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation.印度新出现的多重耐药性耳念珠菌分离株的全基因组测序显示遗传变异较低。
New Microbes New Infect. 2016 Jul 29;13:77-82. doi: 10.1016/j.nmni.2016.07.003. eCollection 2016 Sep.